James Campbell
Amministratore Delegato presso PATRYS LIMITED
Patrimonio netto: 118 472 $ in data 30/04/2024
Provenienza dei contatti di primo grado di James Campbell
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008.
20
| Private Company | Miscellaneous Commercial Services | 20 |
| Public Company | Biotechnology | 13 | |
| Public Company | Pharmaceuticals: Major | 11 | |
| Public Company | Pharmaceuticals: Major | 10 | |
CBio Ltd.
 CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia.
7
| Extinct | Biotechnology | 7 |
| Public Company | Packaged Software | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a James Campbell tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Graduate Degree | |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Monash University
 Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| The University of Queensland | College/University | Graduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
| The Institute of Chartered Accountants in Australia | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
| BioMelbourne Network | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Investment Managers | Private Equity Investor Private Equity Investor Chief Executive Officer | |
| The University of New South Wales | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| CSL LIMITED | Biotechnology | General Counsel General Counsel Chief Tech/Sci/R&D Officer | |
| Deakin University | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree | |
| AVECHO BIOTECHNOLOGY LIMITED | Pharmaceuticals: Major | Director of Finance/CFO Chairman Chairman | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Fibrotech Therapeutics Pty Ltd.
 Fibrotech Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Fibrotech Therapeutics Pty Ltd develops novel drug candidates for the treatment of the fibrosis prevalent in such chronic conditions as kidney disease, chronic heart failure, pulmonary fibrosis, and arthritis. The company was founded by Richard Ernest Gilbert, Darren James Kelly, Spencer J Williams, Steven C Zammit, David Stapleton, Henry Krum and Yuan Zhang in 2006 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Major | Chairman Chief Executive Officer Chief Operating Officer | |
| Australian National University | College/University | Graduate Degree Graduate Degree | |
| Curtin University | College/University | Graduate Degree Undergraduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Chronic Airway Therapeutics
 Chronic Airway Therapeutics BiotechnologyHealth Technology Chronic Airway Therapeutics develops treatments for chronic respiratory diseases. The private company is based in Kew East, Australia. The CEO of the Australian company is Mitchell Glass. | Biotechnology | Chief Executive Officer Chairman | |
| University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal | |
| Griffith University | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Western Australia | College/University | Doctorate Degree Doctorate Degree | |
| VIRALYTICS LTD. | Biotechnology | Chairman Director/Board Member | |
| PHOSCO LTD | Other Metals/Minerals | Director/Board Member Corporate Secretary | |
| OPTHEA LIMITED | Biotechnology | Director/Board Member Founder | |
Certa Therapeutics Pty Ltd.
 Certa Therapeutics Pty Ltd. BiotechnologyHealth Technology Certa Therapeutics Pty Ltd. operates as biotechnology company. The firm develops drugs for treatment for kidney disease. The company was founded by Darren James Kelly and is headquartered in Melbourne, Australia. | Biotechnology | Director/Board Member Chief Executive Officer | |
| 3D ENERGI LIMITED | Integrated Oil | Director of Finance/CFO Corporate Secretary | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree | |
OccuRx Pty Ltd
 OccuRx Pty Ltd BiotechnologyHealth Technology OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia. | Biotechnology | Chairman Founder | |
| COPPER STRIKE LIMITED | Other Metals/Minerals | Corporate Secretary Corporate Secretary | |
QUE Oncology, Inc.
 QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology QUE Oncology, Inc. engages in preventing and treating life-threatening cancers such as prostate cancer, breast cancer, melanoma, and cancer pain; and related conditions. The company is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| RIMFIRE PACIFIC MINING LIMITED | Other Metals/Minerals | Corporate Secretary Corporate Secretary | |
| STARPHARMA HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Vaxxas Pty Ltd.
 Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | Medical Specialties | Director/Board Member Director/Board Member | |
| MACRO METALS LIMITED | Steel | Corporate Secretary Corporate Secretary | |
Global Kinetics Pty Ltd.
 Global Kinetics Pty Ltd. Medical SpecialtiesHealth Technology Global Kinetics Pty Ltd. provides point of care measurement and reporting of Parkinson's disease motor symptoms. Its product includes Personal KinetiGraph (PKG), a wrist worn medical device which reminds the patient when they have taken Levodopa medication as prescribed by doctor. The company was founded by Robert Griffiths and Malcolm Horne in 2007 and is headquartered in Melbourne, Australia. | Medical Specialties | Director/Board Member Director/Board Member | |
| University of California, Los Angeles | College/University | Doctorate Degree Doctorate Degree | |
| RACE ONCOLOGY LIMITED | Pharmaceuticals: Major | Founder Director/Board Member | |
Translational Genomics Research Institute
 Translational Genomics Research Institute Miscellaneous Commercial ServicesCommercial Services Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Polar Ventures Ltd.
 Polar Ventures Ltd. Financial ConglomeratesFinance Polar Ventures Ltd. provides investment services. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Doctorate Degree Undergraduate Degree | |
PolyActiva Pty Ltd.
 PolyActiva Pty Ltd. BiotechnologyHealth Technology PolyActiva Pty Ltd. develops drug-polymer conjugate technology. Its platform technology is used to make plastic components for medical devices from drugs and manufacture process is novel and provides greater flexibility over the composition of the final material and better product outcomes compared with competitor technologies. The firm has built drug-polymer conjugates from a number of drug candidates with different chemical structures and linkage points, demonstrating the plasticity of the technology and developed a number of functional co-monomers and polymer segments, which modularises the production of the final conjugate. The company was founded in February 2010 and is headquartered in Melbourne, Australia. | Biotechnology | Chairman | |
| Athena Medicines Pty Ltd. | Director/Board Member | ||
| EBR SYSTEMS, INC. | Medical Specialties | Director/Board Member | |
| PERCHERON THERAPEUTICS LIMITED | Pharmaceuticals: Major | Chairman | |
Cardiora Pty Ltd.
 Cardiora Pty Ltd. Investment Trusts/Mutual FundsMiscellaneous Cardiora Pty Ltd. functions as a clinical stage pharmaceutical company. It develops CRD-102, an oral medicine for heart failure. The company was founded by David Kaye in 2015 and is headquartered in Melbourne, Australia. | Investment Trusts/Mutual Funds | Director/Board Member | |
Azura Ophthalmics Pty Ltd.
 Azura Ophthalmics Pty Ltd. Medical SpecialtiesHealth Technology Azura Ophthalmics Ltd. develops therapies for meibomian gland dysfunction. It offers a portfolio of compounds in combination with a novel drug delivery platform to advance a portfolio of treatments for meibomian gland dysfunction. The company was founded by Yair Alster in 1980 and is headquartered in Tel Aviv, Israel. | Medical Specialties | Director/Board Member | |
Baker Heart & Diabetes Institute
 Baker Heart & Diabetes Institute Miscellaneous Commercial ServicesCommercial Services Baker Heart & Diabetes Institute owns and operates a medical research institute. The company is headquartered in Melbourne, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of the Witwatersrand | College/University | Undergraduate Degree | |
| Australian Catholic University | College/University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Australia | 39 |
| Stati Uniti | 11 |
| Israele | 2 |
| Sud Africa | 2 |
Settori
| Health Technology | 20 |
| Consumer Services | 16 |
| Commercial Services | 5 |
| Non-Energy Minerals | 5 |
| Finance | 3 |
Posizioni
| Director/Board Member | 289 |
| Corporate Officer/Principal | 148 |
| Corporate Secretary | 110 |
| Chairman | 84 |
| Independent Dir/Board Member | 65 |
Contatti più connessi
| Insiders | |
|---|---|
| Melanie Leydin | 70 |
| Franklyn Prendergast | 43 |
| Paul Hopper | 33 |
| Chris Nave | 24 |
| James Brett Lochran Heading | 24 |
| Ralph Craven | 23 |
| Garner William | 22 |
| Steven Engle | 19 |
| Pamela Klein | 19 |
| Sam di Giacomo | 19 |
| Stephen Thompson | 18 |
| Vincent Fayad | 18 |
| Dean Moss | 17 |
| Chris Indermaur | 15 |
| Sean Henbury | 15 |
- Borsa valori
- Insiders
- James Campbell
- Connessioni Società
